1-11 of 11
Douglas Joshua
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma Based on Cytogenetic Risk Status: Subgroup Analysis from the Phase 3 Study Endeavor (NCT01568866)

Wee-Joo Chng, Hartmut Goldschmidt, Meletios A. Dimopoulos, Philippe Moreau, Douglas Joshua, Antonio Palumbo, Thierry Facon, Heinz Ludwig, Ludek Pour, MD, Ruben Niesvizky, Albert Oriol, MD, Laura Rosinol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Roman Hájek
Journal: Blood
Blood (2015) 126 (23): 30.
https://doi.org/10.1182/blood.V126.23.30.30
Published: 2015
Journal Articles

Impact of Prior Treatment on Patients with Relapsed Multiple Myeloma Treated with Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in a Subgroup Analysis of the Phase 3 Endeavor Study (NCT01568866)

Philippe Moreau, Douglas Joshua, Wee-Joo Chng, Antonio Palumbo, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Heinz Ludwig, Ludek Pour, MD, Ruben Niesvizky, Albert Oriol, MD, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Meletios Dimopoulos
Journal: Blood
Blood (2015) 126 (23): 729.
https://doi.org/10.1182/blood.V126.23.729.729
Published: 2015
Journal Articles

Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)

Stuart D Russell, Alexander Lyon, Daniel J. Lenihan, MD, Philippe Moreau, Douglas Joshua, Wee-Joo Chng, Antonio Palumbo, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Heinz Ludwig, Ludek Pour, MD, Ruben Niesvizky, Albert Oriol, MDPhD, Laura Rosiñol, MDPhD, Aleksandr Suvorov, Gianluca Gaidano, Vesselina Goranova-Marinova, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Meletios A. Dimopoulos
Journal: Blood
Blood (2015) 126 (23): 4250.
https://doi.org/10.1182/blood.V126.23.4250.4250
Published: 2015
Journal Articles

Carfilzomib and Dexamethasone Vs Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: Results of the Phase 3 Study Endeavor (NCT01568866) According to Age Subgroup

Antonio Palumbo, Meletios A. Dimopoulos, Philippe Moreau, Wee-Joo Chng, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Heinz Ludwig, Ludek Pour, MD, Ruben Niesvizky, Albert Oriol, MD, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Heidi H. Gillenwater, Nehal Mohamed, Shibao Feng, Douglas Joshua
Journal: Blood
Blood (2015) 126 (23): 1844.
https://doi.org/10.1182/blood.V126.23.1844.1844
Published: 2015
Journal Articles

CD86 + or HLA-G + can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis

Ross Brown, Karieshma Kabani, James Favaloro, Shihong Yang, P. Joy Ho, John Gibson, Phillip Fromm, Hayley Suen, Narelle Woodland, Najah Nassif, Derek Hart, Douglas Joshua
Journal: Blood
Blood (2012) 120 (10): 2055–2063.
https://doi.org/10.1182/blood-2012-03-416792
Published: 2012
Journal Articles

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

Clinical Trials & Observations
Meletios Dimopoulos, Robert Kyle, Jean-Paul Fermand, S. Vincent Rajkumar, Jesus San Miguel, Asher Chanan-Khan, Heinz Ludwig, Douglas Joshua, Jayesh Mehta, Morie Gertz, Hervé Avet-Loiseau, Meral Beksaç, Kenneth C. Anderson, Philippe Moreau, Seema Singhal, Hartmut Goldschmidt, Mario Boccadoro, Shaji Kumar, Sergio Giralt, Nikhil C. Munshi, Sundar Jagannath, on behalf of the International Myeloma Workshop Consensus Panel 3
Journal: Blood
Blood (2011) 117 (18): 4701–4705.
https://doi.org/10.1182/blood-2010-10-299529
Published: 2011
Journal Articles

Clonal Expansions of Cytotoxic T Cells in the Blood of Patients with Waldenstrom's Macroglobulinaemia Are Anergic and Disappear After Nucleoside Analogue Therapy.

Ross D Brown, Jia Li, Daniel Sze, Mark Cowley, Warren Kaplan, Shihong Yang, Esther Aklilu, Karieshma Kabani, Phoebe Joy Ho, Yen S Loh, Tetsuo Yamagishi, Suilin Mo, Yuling Chen, Douglas Joshua
Journal: Blood
Blood (2009) 114 (22): 1820.
https://doi.org/10.1182/blood.V114.22.1820.1820
Published: 2009
Journal Articles

Characterization of Bortezomib Resistance in Multiple Myeloma Cell Lines

Silvia CW Ling, MBBS, FRCPA, FRACP, Angela M Nikolic, BSc, Ammira Al-Shabeeb, BVM, MSc, PhD, Edwin Lau, BSc, Phoebe Joy Ho, MBBS, FRCPA, FRACP, DPhil, Douglas Joshua, BSc, MBBS(Sydney), DPhil(Oxon), John D Allen, BSc, PhD
Journal: Blood
Blood (2008) 112 (11): 2639.
https://doi.org/10.1182/blood.V112.11.2639.2639
Published: 2008
Journal Articles

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

Clinical Trials & Observations
Heinz Ludwig, Brian G. M. Durie, Vanessa Bolejack, Ingemar Turesson, Robert A. Kyle, Joan Blade, Rafael Fonseca, Meletios Dimopoulos, Kazuyuki Shimizu, Jesus San Miguel, Jan Westin, Jean-Luc Harousseau, Meral Beksac, Mario Boccadoro, Antonio Palumbo, Bart Barlogie, Chaim Shustik, Michele Cavo, Philip R. Greipp, Douglas Joshua, Michel Attal, Pieter Sonneveld, John Crowley
Journal: Blood
Blood (2008) 111 (8): 4039–4047.
https://doi.org/10.1182/blood-2007-03-081018
Published: 2008
Includes: Supplemental data
Journal Articles

An Oral Iron Chelator and Quality of Life.

Richard De Abreu Lourenco, Richard Osborne, Andrew Dalton, Jennifer Houltram, David Dowton, Douglas Joshua, Phoebe Joy Ho, Robert Lindeman
Journal: Blood
Blood (2005) 106 (11): 5553.
https://doi.org/10.1182/blood.V106.11.5553.5553
Published: 2005
Journal Articles

A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine

Clinical Trials & Observations
Kenneth F. Bradstock, Jane P. Matthews, Raymond M. Lowenthal, Heather Baxter, John Catalano, Timothy Brighton, Devinder Gill, Paul Eliadis, Douglas Joshua, Paul Cannell, Anthony P. Schwarer, Simon Durrant, Anne Gillett, Jerry Koutts, Kerry Taylor, John Bashford, Christopher Arthur, Arno Enno, Lindsay Dunlop, Jeff Szer, Michael Leahy, Surender Juneja, Graham A. R. Young, for the Australasian Leukaemia and Lymphoma Group
Journal: Blood
Blood (2005) 105 (2): 481–488.
https://doi.org/10.1182/blood-2004-01-0326
Published: 2005